Stories

At Ipsen, our strategy is anchored in the principle of taking calculated risks to drive innovation. We inspire our employees to embrace innovation and approach risk-taking with a strategic mindset, ensuring that it aligns with our company’s objectives and ethical guidelines.

At Ipsen, our commitment to supporting para-athletes is deeply aligned with our core values of cultivating and embracing diversity. By standing alongside these incredible athletes, we demonstrate our dedication to fostering an inclusive environment where every individual is valued and encouraged to

The first six months of 2024 saw excellent sales growth of 9.5% at CER, and a core operating margin of 32.4%. In light of these strong results, we raised our 2024 total-sales guidance to over 7% growth, with a core operating margin of over 30%.

During the European Association for the Study of the Liver (EASL) congress, leading liver experts, Dr Mark Swain, Dr Emma Culver, and Dr Marco Carbone, sat down to discuss the effective management of primary biliary cholangitis (PBC)

The financial results for the first half of the year will be published on July 25, 2024 at 7H00 and a conference call will take place at 13H00 CET.